Clinical Trials Logo

Advanced Biliary Cancer clinical trials

View clinical trials related to Advanced Biliary Cancer.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04809142 Recruiting - Clinical trials for Advanced Biliary Cancer

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer

Start date: February 4, 2021
Phase: Phase 3
Study type: Interventional

This study is a randomized, parallel controlled, multicentre phase III clinical trial to evaluate the efficacy and safety of TQB2450 combined with anlotinib versus chemotherapy as second-line treatment in subjects with advanced biliary cancer.